Relevance of pept1 in the intestinal permeability and oral absorption of cefadroxil

Pharmaceutical Research

Volumn 30, Issue 4, 2013, Pages 1017-1025

  Posada, Maria M ^a   Smith, David E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

cefadroxil; intestinal permeability; knockout mice; oral absorption; PepT1

Indexed keywords

4 AMINOHIPPURIC ACID; CEFADROXIL; CEFALEXIN; CEFALOTIN; GLYCINE; GLYCYLPROLINE; GLYCYLSARCOSINE; HISTIDINE; N METHYLNICOTINAMIDE; PEPTIDE TRANSPORTER 1;

ANIMAL EXPERIMENT; ARTICLE; COLON; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DUODENUM; FEMALE; GENE SILENCING; ILEUM; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFUSION; JEJUNUM; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; WILD TYPE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; CEFADROXIL; FEMALE; GENE KNOCKOUT TECHNIQUES; INTESTINES; MALE; MICE; MICE, KNOCKOUT; PERMEABILITY; SYMPORTERS;

EID: 84876481462     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0937-8     Document Type: Article

References (40)

1. Daniel H, Spanier B, Kottra G, Weitz D. From bacteria to man: archaic proton-dependent peptide transporters at work. Physiology. 2006;21:93-102.
2. Rubio-Aliaga I, Daniel H. Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica. 2008;38:1022-42.
3. Brandsch M, Knutter I, Bosse-Doenecke E. Pharmaceutical and pharmacological importance of peptide transporters. J Pharm Pharmacol. 2008;60:543-85.
4. Smith DE, Clémençon B, Hediger MA. Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Aspects Med. (2013).
5. Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF, et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature. 1994;368:563-6.
6. Shen H, Smith DE, Yang T, Huang YG, Schnermann JB, Brosius 3rd FC. Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am J Physiol. 1999;276:F658-65.
7. Jappar D, Wu SP, Hu Y, Smith DE. Significance and regional dependency of peptide transporter (PEPT) 1 in the intestinal permeability of glycylsarcosine: in situ single-pass perfusion studies in wild-type and Pept1 knockout mice. Drug Metab Dispos. 2010;38:1740-6.
8. Tanrisever B, Santella PJ. Cefadroxil: a review of its antibacterial, pharmacokinetic and therapeutic properties in comparison with cephalexin and cephradine. Drugs. 1986;32 Suppl 3:1-16.
9. Buck RE, Price KE. Cefadroxil, a new broad-spectrum cephalosporin. Infection. 1980;8 Suppl 5:S532-7.
10. Tsuji A. Intestinal absorption of β-lactam antibiotics. In: Taylor MD, Amidon GL, editors. Peptide-based drug design. Washington: American Chemical Society; 1995. p. 101-34.
11. Boll M, Markovich D, Weber W-M, Korte H, Daniel H, Murer H. Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, β-lactam antibiotics and ACE-inhibitors. Pflügers Arch Eur J Physiol. 1994;429:146-9.
12. Sinko PJ, Amidon GL. Characterization of the oral absorption of beta-lactam antibiotics. I. Cephalosporins: determination of intrinsic membrane absorption parameters in the rat intestine in situ. Pharm Res. 1988;5:645-50.
13. Sánchez-Picó A, Peris-Ribvera J-E, Toledano C, Torres-Molina F, Casabó V-G, Martín-Villodre A, et al. Non-linear intestinal absorption kinetics of cefadroxil in the rat. J Pharm Pharmacol. 1989;41:179-85.
14. Wenzel U, Gebert I, Weintraut H, Weber W-M, Clauß W, Daniel H. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PEPT1 and in human intestinal Caco-2 cells. J Pharmacol Exp Ther. 1996;277:831-9.
15. Shen H, Ocheltree SM, Hu Y, Keep RF, Smith DE. Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos. 2007;35:1209-16.
16. Ocheltree SM, Shen H, Hu Y, Xiang J, Keep RF, Smith DE. Mechanisms of cefadroxil uptake in the choroid plexus: studies in wild-type and PEPT2 knockout mice. J Pharmacol Exp Ther. 2004;308:462-7.
17. Shen H, Keep RF, Hu Y, Smith DE. PEPT2 (Slc15a2)-mediated unidirectional transport of cefadroxil from cerebrospinal fluid into choroid plexus. J Pharmacol Exp Ther. 2005;315:1101-8.
18. Takeda M, Babu E, Narikawa S, Endou H. Interaction of human organic anion transporters with various cephalosporin antibiotics. Eur J Pharmacol. 2002;438:137-42.
19. Khamdang S, Takeda M, Babu E, Noshiro R, Onozato ML, Tojo A, et al. Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. Eur J Pharmacol. 2003;465:1-7.
20. Ueo H, Motohashi H, Katsura T, Inui K-I. Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol. 2005;70:1104-13.
21. Nakakariya M, Shimada T, Irokawa M, Koibuchi H, Iwanaga T, Yabuuchi H, et al. Predominant contribution of rat organic anion transporting polypeptide-2 (Oatp2) to hepatic uptake of beta-lactam antibiotics. Pharm Res. 2008;25:578-85.
22. Hu Y, Smith DE, Ma K, Jappar D, Thomas W, Hillgren KM. Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine. Mol Pharm. 2008;5:1122-30.
23. Komiya I, Park JY, Kamani A, Ho NFH, Higuchi WI. Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes. Int J Pharm. 1980;4:249-62.
24. Kou JH, Fleisher D, Amidon GL. Calculation of the aqueous diffusion layer resistance for absorption in a tube: application to intestinal membrane permeability determination. Pharm Res. 1991;8:298-305.
25. Johnson DA, Amidon GL. Determination of intrinsic membrane transport parameters from perfused intestine experiments: a boundary layer approach to estimating the aqueous and unbiased membrane permeabilities. J Theor Biol. 1988;131:93-106.
26. Fagerholm U, Johansson M, Lennernäs H. Comparison between permeability coefficients in rat and human jejunum. Pharm Res. 1996;13:1336-42.
27. Lennernäs H. Animal data: the contributions of the Ussing chamber and perfusion systems to predicting human oral drug delivery in vivo. Adv Drug Deliv Rev. 2007;59:1103-20.
28. Jappar D, Hu Y, Smith DE. Effect of dose escalation on the in vivo oral absorption and disposition of glycylsarcosine in wild-type and Pept1 knockout mice. Drug Metab Dispos. 2011;39:2250-7.
29. Bretschneider B, Brandsch M, Neubert R. Intestinal transport of β-lactam antibiotics: analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm Res. 1999;16:55-61.
30. Ganapathy ME, Brandsch M, Prasad PD, Ganapathy V, Leibach FH. Differential recognition of β-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J Biol Chem. 1995;270:25672-7.
31. 1 cells. Am J Physiol Ren Physiol. 1997;273:F706-11.
32. Naruhashi K, Sai Y, Tamai I, Suzuki N, Tsuji A. PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of cefadroxil longitudinally in the rat intestine. Pharm Res. 2002;19:1417-23.
33. Oulianova N, Cheng D, Huebert N, Chen Y. Human oral drugs absorption is correlated to their in vitro uptake by brush border membrane vesicles. Int J Pharm. 2007;336:115-21.
34. Lucas M. Determination of acid surface pH in vivo in rat proximal jejunum. Gut. 1983;24:734-9.
35. Högerle ML, Winne D. Drug absorption by the rat jejunum perfused in situ. dissociation from the pH-partition theory and role of microclimate-pH and unstirred layer. Naunyn-Schmiedeberg's Arch Pharmacol. 1983;322:249-55.
36. Dressman J, Butler J, Hempenstall J, Reppas C. The BCS: where do we go from here? Pharm Technol. 2001;25:68-76.
37. Butler JM, Dressman JB. The developability classification system: application of biopharmaceutics concepts to formulation development. J Pharm Sci. 2010;99:4940-54.
38. La Rosa F, Ripa S, Prenna M, Ghezzi A, Pfeffer M. Pharmacokinetics of cefadroxil after oral administration in humans. Antimicrob Agents Chemother. 1982;21:320-2.
39. Garrigues TM, Martin U, Peris-Ribera JE, Prescott LF. Dose-dependent absorption and elimination of cefadroxil in man. Eur J Clin Pharmacol. 1991;41:179-83.
40. Ma K, Hu Y, Smith DE. Influence of fed-fasted state on intestinal PEPT1 expression and in vivo pharmacokinetics of glycylsarcosine in wild-type and Pept1 knockout mice. Pharm Res. 2012;29:535-45.